Published in HPB (Oxford) on March 01, 2009
Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol (2012) 1.50
Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB (Oxford) (2012) 1.01
Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. J Am Coll Surg (2014) 0.91
Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases. World J Gastroenterol (2013) 0.79
Sequential preoperative hepatic vein embolization after portal vein embolization for extended left hepatectomy in colorectal liver metastases. World J Surg Oncol (2013) 0.77
The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review. World J Surg Oncol (2017) 0.75
Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg (2000) 5.79
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg (2004) 5.10
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol (2004) 4.78
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg (2004) 3.72
Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 3.16
Strategies for safer liver surgery and partial liver transplantation. N Engl J Med (2007) 3.14
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg (2006) 3.05
Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg (2005) 3.04
Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol (2006) 2.71
Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl (2006) 2.55
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg (2007) 2.40
During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg (1999) 2.37
Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg (2000) 2.32
A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg (2004) 2.20
Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg (2008) 2.10
Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg (2003) 2.05
Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg (1999) 1.94
Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology (2001) 1.91
Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg (2008) 1.85
Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg (2003) 1.56
Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology (2004) 1.38
Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg (2007) 1.35
Presurgical chemotherapy in patients being considered for liver resection. Oncologist (2007) 1.24
Hepatic colorectal metastases: methods of improving resectability. Surg Clin North Am (2004) 1.14
Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery (2002) 1.09
Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery (2008) 1.07
Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg (2006) 0.99
Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes. J Surg Oncol (2007) 0.96
Fate of the human liver after hemihepatic portal vein embolization: cell kinetic and morphometric study. Hepatology (1997) 0.96
Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br J Radiol (2006) 0.95
A prospective study of isolated human hepatocyte function following liver resection for colorectal liver metastases: the effects of prior exposure to chemotherapy. J Hepatol (2006) 0.92
Hepatectomy for resectable colorectal cancer metastases--indicators of prognosis, definition of resectability, techniques and outcomes. Surg Oncol Clin N Am (2007) 0.88
A scientist revisits the atrophy-hypertrophy complex: hepatic apoptosis and regeneration. Surg Oncol Clin N Am (2002) 0.86
Effects of postoperative adjuvant chemotherapy on liver regeneration in partially hepatectomized rats. Jpn J Surg (1984) 0.81
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study. Lancet Oncol (2011) 3.44
Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol (2006) 2.71
Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl (2006) 2.55
Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study. Lancet (2008) 2.36
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension. J Gastroenterol Hepatol (2012) 1.52
A comparison of intrathecal morphine/fentanyl and patient-controlled analgesia with patient-controlled analgesia alone for analgesia after liver resection. Anesth Analg (2006) 1.17
Transfusion predictors in liver transplant. Anesth Analg (2004) 1.16
The contribution of structured activity and deliberate play to the development of expert perceptual and decision-making skill. J Sport Exerc Psychol (2008) 1.09
Neurobiological characterization of an azoxymethane mouse model of acute liver failure. Neurochem Int (2006) 1.07
Learning from the experts: practice activities of expert decision makers in sport. Res Q Exerc Sport (2003) 1.06
Coagulation defects do not predict blood product requirements during liver transplantation. Transplantation (2008) 1.05
Mild hypothermia attenuates liver injury and improves survival in mice with acetaminophen toxicity. Gastroenterology (2006) 1.04
Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer. Can Urol Assoc J (2007) 1.02
Impact of localized congestion related to venous deprivation after hepatectomy. Surgery (2008) 0.97
Survival rate changes with transfusion of blood products during liver transplantation. Can J Anaesth (2005) 0.96
Effects of repeated distension arthrographies combined with a home exercise program among adults with idiopathic adhesive capsulitis of the shoulder. Am J Phys Med Rehabil (2004) 0.96
Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study. Can J Gastroenterol (2006) 0.95
Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival. Transplantation (2011) 0.91
Transfusion rate for 500 consecutive liver transplantations: experience of one liver transplantation center. Transplantation (2012) 0.91
Patterns of early involvement in expert and nonexpert masters triathletes. Res Q Exerc Sport (2006) 0.91
Nuclear FGF-2 facilitates cell survival in vitro and during establishment of metastases. Oncogene (2004) 0.90
Reduction of blood product transfusions during liver transplantation. Can J Anaesth (2005) 0.89
Cure of gastric antral vascular ectasia by liver transplantation despite persistent portal hypertension: a clue for pathogenesis. Liver Transpl (2002) 0.87
MELD score and blood product requirements during liver transplantation: no link. Transplantation (2009) 0.87
Harvesting the middle hepatic vein with a right hepatectomy does not increase the risk for the donor. Liver Transpl (2004) 0.87
Helical CT with CT angiography in assessing periampullary neoplasms: identification of vascular invasion. Radiology (2002) 0.87
A proposed theoretical model to explain relative age effects in sport. Eur J Sport Sci (2013) 0.87
Evaluation of cell salvage autotransfusion utility during liver transplantation. HPB (Oxford) (2007) 0.86
Examination of birthplace and birthdate in World Junior ice hockey players. J Sports Sci (2011) 0.86
Effects of phlebotomy and phenylephrine infusion on portal venous pressure and systemic hemodynamics during liver transplantation. Transplantation (2010) 0.84
Is intra-operative ultrasound still useful for the detection of a hepatic tumour in the era of modern pre-operative imaging? HPB (Oxford) (2011) 0.84
Identification of new donor variables associated with graft survival in a single-center liver transplant cohort. Liver Transpl (2010) 0.83
Evaluation of the addition of bupivacaine to intrathecal morphine and fentanyl for postoperative pain management in laparascopic liver resection. Reg Anesth Pain Med (2010) 0.80
Carcinoid tumor of the common bile duct: a rare complication of von Hippel-Lindau syndrome. World J Gastroenterol (2008) 0.79
Independent validation of a model predicting the need for packed red blood cell transfusion at liver transplantation. Transplantation (2009) 0.79
[Nephrogenic systemic fibrosis: more hard times for renal failure patients]. Nephrol Ther (2007) 0.78
Gastrointestinal stromal tumours: etiology, pathology and clinical management. Can J Gastroenterol (2004) 0.78
Comparison of bupivacaine and 2-chloroprocaine for spinal anesthesia for outpatient surgery: a double-blind randomized trial. Can J Anaesth (2011) 0.78
A primer to common major gastrointestinal post-surgical anatomy on CT-a pictorial review. Insights Imaging (2011) 0.77
Long-lasting analgesic effects of intraoperative thoracic epidural with bupivacaine for liver resection. Reg Anesth Pain Med (2010) 0.77
From early to adult sport success: analysing athletes' progression in national squads. Eur J Sport Sci (2012) 0.76
Birthplace effects on the development of female athletic talent. J Sci Med Sport (2007) 0.75
Interferon beta-induced panniculitis mimicking acute appendicitis. Arch Dermatol (2009) 0.75
Answer to case of the month #162. Emphysematous infection of the liver parenchyma. Can Assoc Radiol J (2010) 0.75
Hepatic rupture in hemolysis, elevated liver enzymes, low platelets syndrome. Obstet Gynecol (2012) 0.75
Bullying Victimization and Perpetration Among Adolescent Sport Teammates. Pediatr Exerc Sci (2015) 0.75
Extensive high-grade intraductal papillary neoplasm: what is the optimal treatment strategy? Liver Transpl (2012) 0.75
Cutaneous Apocrine Carcinoma With an In Situ Component and Histiocytoid and Signet-Ring Cells. Am J Dermatopathol (2017) 0.75
Relationship between conventional coagulation tests and bleeding for 600 consecutive liver transplantations. Transplantation (2014) 0.75